Condition
Seborrheic Keratosis (SK)
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07441538Not ApplicableCompleted
Optimizing the Timing for Facial Surgical Dressing Removal
NCT07384299Completed
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
NCT07095348CompletedPrimary
Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis
NCT01986920Phase 1CompletedPrimary
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Showing all 4 trials